PCG
SRNE

Private Capital Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Private Capital Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-47
Closed – – 2194
2019
Q4 		$0 Hold
47
– – ﹤0.01% 2243
2019
Q3 		$0 Buy
+47
New +$110 ﹤0.01% 2500
2019
Q2 		– Sell
-47
Closed – – 2462
2019
Q1 		$0 Hold
47
– – ﹤0.01% 2339
2018
Q4 		$0 Buy
+47
New +$153 ﹤0.01% 2374

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Private Capital Group's SRNE Position: Q1 2020 in Review

Private Capital Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2020, closing a stake of 47 shares.

Private Capital Group first reported a position in SRNE in Q4 2018 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 92 funds tracked by Wall St. Rank hold SRNE as of Q1 2020.

  • Private Capital Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Private Capital Group sold 47 Sorrento Therapeutics, Inc. shares in Q1 2020.
  • Private Capital Group first reported a position in Sorrento Therapeutics, Inc. in Q4 2018 and held it in 4 quarters.
  • Private Capital Group's Sorrento Therapeutics, Inc. position peaked at $0 in Q4 2019.
  • 92 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.